➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
AstraZeneca
Harvard Business School
Merck
McKesson

Last Updated: April 18, 2021

DrugPatentWatch Database Preview

Felodipine - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for felodipine and what is the scope of freedom to operate?

Felodipine is the generic ingredient in two branded drugs marketed by Aurobindo Pharma Ltd, Glenmark Generics, Heritage Pharms Inc, Jubilant Generics, Mylan, Orchid Hlthcare, Sun Pharm Inds Ltd, Sun Pharm Industries, Torrent Pharms Ltd, Vintage Pharms Llc, Wockhardt Ltd, Yiling, Yung Shin Pharm, and Astrazeneca, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for felodipine. Fifteen suppliers are listed for this compound.

Summary for felodipine
Drug Prices for felodipine

See drug prices for felodipine

Drug Sales Revenue Trends for felodipine

See drug sales revenues for felodipine

Recent Clinical Trials for felodipine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Rigshospitalet, DenmarkPhase 4
Lawson Health Research InstitutePhase 1
Lee's Pharmaceutical LimitedPhase 4

See all felodipine clinical trials

Pharmacology for felodipine
Medical Subject Heading (MeSH) Categories for felodipine
Paragraph IV (Patent) Challenges for FELODIPINE
Tradename Dosage Ingredient NDA Submissiondate
PLENDIL TABLET, EXTENDED RELEASE;ORAL felodipine 019834

US Patents and Regulatory Information for felodipine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vintage Pharms Llc FELODIPINE felodipine TABLET, EXTENDED RELEASE;ORAL 200815-001 Oct 28, 2011 AB RX No No   Start Trial   Start Trial   Start Trial
Vintage Pharms Llc FELODIPINE felodipine TABLET, EXTENDED RELEASE;ORAL 200815-003 Oct 28, 2011 AB RX No No   Start Trial   Start Trial   Start Trial
Glenmark Generics FELODIPINE felodipine TABLET, EXTENDED RELEASE;ORAL 090365-001 Dec 17, 2010 AB RX No No   Start Trial   Start Trial   Start Trial
Heritage Pharms Inc FELODIPINE felodipine TABLET, EXTENDED RELEASE;ORAL 201964-003 Nov 8, 2013 AB RX No No   Start Trial   Start Trial   Start Trial
Torrent Pharms Ltd FELODIPINE felodipine TABLET, EXTENDED RELEASE;ORAL 202170-003 Nov 28, 2011 AB RX No Yes   Start Trial   Start Trial   Start Trial
Sun Pharm Inds Ltd FELODIPINE felodipine TABLET, EXTENDED RELEASE;ORAL 091200-002 Dec 13, 2013 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for felodipine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca PLENDIL felodipine TABLET, EXTENDED RELEASE;ORAL 019834-001 Jul 25, 1991   Start Trial   Start Trial
Astrazeneca PLENDIL felodipine TABLET, EXTENDED RELEASE;ORAL 019834-004 Sep 22, 1994   Start Trial   Start Trial
Astrazeneca PLENDIL felodipine TABLET, EXTENDED RELEASE;ORAL 019834-002 Jul 25, 1991   Start Trial   Start Trial
Astrazeneca PLENDIL felodipine TABLET, EXTENDED RELEASE;ORAL 019834-002 Jul 25, 1991   Start Trial   Start Trial
Astrazeneca PLENDIL felodipine TABLET, EXTENDED RELEASE;ORAL 019834-004 Sep 22, 1994   Start Trial   Start Trial
Astrazeneca PLENDIL felodipine TABLET, EXTENDED RELEASE;ORAL 019834-001 Jul 25, 1991   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Johnson and Johnson
Mallinckrodt
Colorcon
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.